The Relationship Between Irisin and Bone Health in Individuals With Spinal Cord Injury (IBSCI)
The Influence of Irisin/FNDC5 on Bone Mineral Density and Fracture Risk in Individuals With Spinal Cord Injury
Sponsor: VA Office of Research and Development
This NA trial investigates Spinal Cord Injury and is currently completed. VA Office of Research and Development leads this study, which shows 14 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
-
Jun 2025 — Aug 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2025 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Apr 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Not Yet Recruiting NA
-
Mar 2023 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Mar 2023 [monthly]
Not Yet Recruiting NA
-
Nov 2022 — Jan 2023 [monthly]
Not Yet Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting NA
-
May 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .